Mental health has long been a taboo topic in many communities, and the ultra-Orthodox world is no exception. While ...
Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market ...
US FDA accepts for priority review Sanofi & Regeneron’s Dupixent sBLA for the targeted treatment of bullous pemphigoid: Paris Wednesday, February 19, 2025, 12:00 Hrs [IST] The U ...
21 小时on MSN
What you should knowA 4-alarm fire broke out shortly after 9:30 p.m. Monday at SPS Technologies, an aerospace parts supplier ...
Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for ...
The US Food and Drug Administration (FDA) has accepted for priority review Sanofi’s supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid ...
He is at home in West Hollywood, in a secondary bedroom he has turned into a broadcasting booth. The boiling overhead studio ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果